Don't Just Take Our Word
Discover what previous attendees at the TPD Summit had to say...
"In the rapidly advancing field of TPD research, this summit is an excellent opportunity to see a number of amazing cutting-edge approaches from experts, not only bivalent degraders and molecular glue degraders but also other proximity inducers."
FIMECS
"I really enjoyed the opportunity to connect with others in the field and learn about the latest developments. The sessions were well-organized, and several talks provided fresh perspectives that I found inspiring. What stood out most to me was the quality of the discussions and how engaged the audience was throughout."
Parabilis Medicines
"I enjoyed the wide array of talks spanning the discovery, pre-clinical and clinical stage TPDs. I also enjoyed the panel discussions and fireside chats."
Merck & Co
"This was my first time attending, and it was very beneficial to be exposed to the latest research in this field and to have various discussions with the participants."
Kaken Pharmaceutical Co Ltd
"There were many presentations from companies at the forefront of this industry, so I was able to grasp the latest trends. There was plenty of time for networking, so I was able to communicate with people from various backgrounds. A networking platform was also provided, so I was able to meet with startups."
Daiichi Sankyo
"This is the largest conference in the TPD field, well organized, very informative with lots of exciting advances from clinical development to emerging new technologies, targets and medicinal chemistry. A very rewarding experience."
Hinova
"Lots of different and varied sessions focusing on discovery, preclinical and clinical aspects."
Genosco
"Great scientific presentations from leaders in the field."
Novartis AG
"Great opportunity to catch up with colleagues and hear about great science."
Monte Rosa Therapeutics
"Fantastic meeting with terrific talks and opportunities to mix with colleagues."
University of Nevada School of Medicine
"An array of varied and powerful speakers."
Johnson & Johnson
"A great collection of talks. I also enjoyed meeting other colleagues from other companies and had offline discussions about science and major progresses have been made in the field."
Seed Therapeutics
Explore the 2026 Preliminary Agenda
Explore tracks spanning Academic Frontiers, Discovery, Preclinical Development, Translational and Clinical Development, Latest Tools & Technology and the Future of Induced Proximity.
Partner With Us
Position yourself alongside as the leading solution provider to ensure your brand is at the heart of TPD biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.